home / stock / prph / prph news


PRPH News and Press, ProPhase Labs Inc. From 11/19/25

Stock Information

Company Name: ProPhase Labs Inc.
Stock Symbol: PRPH
Market: NASDAQ
Website: prophaselabs.com

Menu

PRPH PRPH Quote PRPH Short PRPH News PRPH Articles PRPH Message Board
Get PRPH Alerts

News, Short Squeeze, Breakout and More Instantly...

PRPH - ProPhase Labs GAAP EPS of -$0.16, revenue of $0.88M

2025-11-19 08:35:45 ET More on ProPhase Labs Seeking Alpha’s Quant Rating on ProPhase Labs Financial information for ProPhase Labs Read the full article on Seeking Alpha For further details see: ProPhase Labs GAAP EPS of -$0.16, revenue of $0.88M

PRPH - ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.

ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important. Crown Medical Achieves Final Hurdle. Appointed Special Counsel to Launch Litigation Against Insurance Companies. First Settlement Co...

PRPH - ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19

UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting third quarter 2025 financial results on a...

PRPH - ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals

UNIONDALE, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) reminds shareholders of record as of October 20, 2025, of the Company's upcoming Special Meeting of Stockholders, which will be held on November 24, 2025, at 10:00 a.m. ET. Shareholders of record as of October 20,...

PRPH - ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives Expected to Begin in Early 2026 UNIONDALE, NY, Oct. 29, 2025 (GLOB...

PRPH - ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts

UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced that it has engaged RedChip Companies (“RedChip”) to l...

PRPH - ProPhase Labs to Present at the 2025 ThinkEquity Conference

UNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced that it will be participating in the ThinkEquity Conference on Octob...

PRPH - US Companies Moving the Markets, Morning edition
Wed, Oct 22, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States AiRWA Inc. (YYAI) rose 126.0% to $0.182799 on volume of 1,050,185,448 shares Beyond Meat Inc. (BYND) rose 68.8% to $6.11 on volume of 606,305,245 shares Nuburu Inc. (BURU) rose 12.3% to $0.32535 on volume of 153,930,465 shares reAlpha...

PRPH - ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology

Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, g...

PRPH - PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE

COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, anno...

Previous 10 Next 10